1. Home
  2. HRMY vs PEB Comparison

HRMY vs PEB Comparison

Compare HRMY & PEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

SELL

Current Price

$38.04

Market Cap

2.4B

Sector

Health Care

ML Signal

SELL

Logo Pebblebrook Hotel Trust of Beneficial Interest

PEB

Pebblebrook Hotel Trust of Beneficial Interest

SELL

Current Price

$19.55

Market Cap

2.0B

Sector

Real Estate

ML Signal

SELL

Company Overview

Basic Information
Metric
HRMY
PEB
Founded
2017
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2020
2009

Fundamental Metrics

Financial Performance
Metric
HRMY
PEB
Price
$38.04
$19.55
Analyst Decision
Buy
Hold
Analyst Count
12
16
Target Price
★ $48.25
$19.32
AVG Volume (30 Days)
750.6K
★ 1.9M
Earning Date
11-03-2026
10-29-2026
Dividend Yield
N/A
★ 0.21%
EPS Growth
★ 7.97
N/A
EPS
★ 1.84
N/A
Revenue
$868,453,000.00
★ $1,475,544,000.00
Revenue This Year
$18.62
$0.56
Revenue Next Year
$13.23
$2.02
P/E Ratio
$20.62
★ N/A
Revenue Growth
★ 21.51
1.53
52 Week Low
$25.81
$9.99
52 Week High
$43.49
$19.96

Technical Indicators

Market Signals
Indicator
HRMY
PEB
Relative Strength Index (RSI) 42.84 61.73
Support Level $37.48 $17.50
Resistance Level $39.35 $19.73
Average True Range (ATR) 1.28 0.50
MACD -0.24 0.05
Stochastic Oscillator 50.52 69.52

Price Performance

Historical Comparison
HRMY
PEB

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About PEB Pebblebrook Hotel Trust of Beneficial Interest

Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,052 rooms across 44 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under the Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.

Share on Social Networks: